MyStroke Educational Platform for Stroke Management
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how a personalized video-based education platform affects patient satisfaction and knowledge about managing stroke after experiencing one. Participants will either use a new platform called MyStroke or receive standard stroke education from their medical providers. The trial targets individuals who had an ischemic stroke (a type of stroke caused by a blood clot) between 1 and 10 years ago and are currently receiving outpatient care at the Hospital of the University of Pennsylvania. Participants must have access to a smartphone, tablet, or computer and be willing to complete two follow-up surveys.
As an unphased trial, this study allows participants to contribute to innovative research that may enhance stroke recovery education.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on educational aspects rather than medication changes.
What prior data suggests that the MyStroke educational platform is safe for stroke management?
Research has shown that the MyStroke platform, a personalized video-based educational tool, has been well-received by patients and caregivers. Earlier studies indicated that it increased satisfaction without causing harm or discomfort, and no reports of negative effects have emerged. The platform aids stroke survivors by providing information tailored to their needs. It involves no medication or physical treatments, making it generally safe. By focusing on education, it allows participants to learn at their own pace, offering a low-risk option for those considering joining the trial.12345
Why are researchers excited about this trial?
Researchers are excited about the MyStroke educational platform because it offers a personalized, video-based approach to stroke management, unlike the traditional standard education provided by medical staff. This innovative platform tailors information to individual patients, potentially increasing engagement and understanding, which could lead to better management of stroke recovery and prevention. By leveraging multimedia and personalized content, MyStroke aims to enhance patient education beyond the typical pamphlets and verbal instructions, offering insights that could transform how stroke patients learn about and manage their condition.
What evidence suggests that the MyStroke educational platform is effective for stroke management?
Research has shown that the MyStroke educational platform, available to participants in this trial, can enhance stroke patients' satisfaction with their learning experience. In earlier studies, 90% of patients using MyStroke reported satisfaction with the education received, compared to 73% of those receiving standard education. This suggests that personalized videos might improve patients' understanding of their condition. The platform aims to increase stroke knowledge and might reduce the need for healthcare services after hospital discharge. Early findings indicate that MyStroke use could result in better-informed patients who feel more confident in managing their condition.12346
Are You a Good Fit for This Trial?
This trial is for adults who had an ischemic stroke between 1 and 10 years ago, are getting outpatient care at the University of Pennsylvania Hospital, can use a smart device or computer, and are willing to do follow-up surveys. It's not for those who can't use the app, need full-time caregiver help, had their stroke outside the 1-10 year window, or have severe speech difficulties.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either personalized video-based stroke education or standard education
Follow-up
Participants are monitored for stroke knowledge retention and satisfaction
What Are the Treatments Tested in This Trial?
Interventions
- MyStroke
Trial Overview
The MyStroke clinical trial tests a personalized video-based educational platform designed to improve patient satisfaction and knowledge about chronic stroke management. Participants will be randomly assigned to either receive this intervention or not.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Access to a personalized video-based stroke educational platform
Standard stroke patient education as per the medical providers
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Citations
Personalized Video‐Based Educational Platform to ...
At 90 days post‐stroke, those who received MyStroke were more likely to be satisfied with the stroke education the received (90% versus 73%, P= ...
Personalized Video-Based Educational Platform to Improve ...
At 90 days post-stroke, those who received MyStroke were more likely to be satisfied with the stroke education the received (90% versus 73%, P= ...
Study Details | NCT06057753 | MyStroke in Chronic Stroke
This is a single-center randomized control trial assessing the impact of a personalized video-based educational platform on patients satisfaction and stroke ...
MyStroke for Stroke Survivors · Info for Participants
The study measures if this platform can boost stroke knowledge and reduce health system use post-discharge by comparing two groups: one with standard care, ...
MyStroke for Stroke Survivors and Caregivers
The goal of this multicenter randomized trial is to evaluate the impact of a personalized video-based stroke education platform on patient-centered and ...
MyStroke for Stroke Survivors and Caregivers
The MyStroke platform offers a scalable solution stroke education which imposes no burden on the clinical team due to its reliance on a limited ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.